Aurora Cannabis Inc (NASDAQ: ACB) rallied more than 25% this morning after President Trump endorsed cannabidiol (CBD) as potential breakthrough in senior healthcare. In a social media post over the ...

Andrew Kessel was a breaking news writer for Investopedia until October 2025. He previously covered markets for Proactive Investors, with a focus on small-cap stocks in fintech, healthcare, mining, ...

Aurora Cannabis (NASDAQ:ACB) traded higher on Thursday after the company expanded the eligibility for its compassionate pricing program in Canada in a bid to widen access to its medical cannabis ...

Aurora Cannabis Inc. closed 37.77% below its 52-week high of $6.91, which the company reached on February 10th.

Aurora Cannabis ACB is slated to release first-quarter fiscal 2026 results on Aug. 6, before market open. The Zacks Consensus Estimate for earnings and revenues is pegged at 18 cents per share and $70 ...

Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big ...

President Trump's recent nod to CBD sent Aurora Cannabis Inc. stock soaring, but a deeper look reveals why this supposed catalyst fails to address the industry's real challenges. My original 2022 ...

Shares of Aurora Cannabis Inc. ACB slid 2.24% to $4.36 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index COMP falling 1.90% to ...